Intraductal carcinoma in situ of breast digital illustration

Intraductal carcinoma in situ of breast Save


ICD-10 code: D05.1

Chapter: Neoplasms

Intraductal Carcinoma in Situ of Breast: Understanding the Condition

Intraductal carcinoma in situ (DCIS) of the breast is a non-invasive form of breast cancer that develops in the milk ducts of the breast. It is also known as Stage 0 breast cancer. The cancer cells remain confined within the ducts and do not invade the surrounding breast tissue. DCIS is not life-threatening, but it can increase the risk of developing invasive breast cancer if left untreated.

DCIS is usually detected during routine mammography screening or when a lump or abnormality is found during a breast examination. Although there may be no symptoms, some women may experience nipple discharge or a lump in the breast.

Treatment for DCIS

Treatment for DCIS typically involves surgery to remove the cancer cells. The most common surgical procedure is lumpectomy, which involves removing the cancerous tissue along with some surrounding normal tissue. In some cases, a mastectomy may be recommended. This involves removing the entire breast.

After surgery, radiation therapy may be recommended to destroy any remaining cancer cells. Hormone therapy may also be recommended in some cases, particularly if the cancer cells have receptors for estrogen or progesterone.

Prognosis for DCIS

The prognosis for DCIS is generally good, with a 10-year survival rate of almost 100%. However, there is a risk of the cancer returning or developing into invasive breast cancer. Regular follow-up appointments with a healthcare provider are important to monitor for any changes or signs of recurrence.

Conclusion

Intraductal carcinoma in situ of the breast is a non-invasive form of breast cancer that can increase the risk of developing invasive breast cancer if left untreated. Treatment typically involves surgery, radiation therapy, and hormone therapy. The prognosis for DCIS is generally good, but regular follow-up appointments are important to monitor for any changes or signs of recurrence.

  1. Intraductal carcinoma in situ (DCIS) of the breast is a non-invasive form of breast cancer.
  2. DCIS is usually detected during routine mammography screening or when a lump or abnormality is found during a breast examination.
  3. Treatment for DCIS typically involves surgery to remove the cancer cells.
  4. The prognosis for DCIS is generally good, with a 10-year survival rate of almost 100%.
  5. Regular follow-up appointments with a healthcare provider are important to monitor for any changes or signs of recurrence.